Vascular Closure Devices Market Forecast 2024-2033: Growth Rate, Drivers, And Trends|Cardinal Health Inc., Abbott Laboratories, Medtronic PLC, Koninklijke Philips NV, Boston Scientific Corporation

The Vascular Closure Devices Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Vascular Closure Devices Market:
https://www.thebusinessresearchcompany.com/report/vascular-closure-devices-global-market-report

According to The Business Research Company’s Vascular Closure Devices Global Market Report 2024, The vascular closure devices market size has grown strongly in recent years. It will grow from $1.42 billion in 2023 to $1.53 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to growth in minimally invasive procedures, aging population demographics, patient preference for shorter recovery times, increased catheterization lab procedures, focus on outpatient care..

The vascular closure devices market size is expected to see strong growth in the next few years. It will grow to $1.97 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to rise in ambulatory surgery centers, shift toward same-day discharge, patient-centric approaches, healthcare cost containment initiatives, increasing incidence of cardiovascular diseases.. Major trends in the forecast period include adoption of percutaneous coronary intervention, global collaboration in medical research, remote patient monitoring, integration with imaging technologies, technological innovations in device design..

The increasing prevalence of cardiovascular diseases is expected to drive the growth of the vascular closure devices market. Cardiovascular disease (CVD) refers to conditions that affect the structures or function of the heart or blood vessels, affecting blood flow to the heart. Vascular closure devices (VCDs) are a substitute for conventional mechanical compression to close the femoral artery and offer rapid sealing of the femoral artery access site, potentially resulting in quicker attainment of hemostasis and a reduced risk of bleeding or hemorrhage following placement. For instance, in June 2023, according to the Immigration and Checkpoints Authority, a Singapore-based law enforcement agency, the number of people who died from heart and hypertensive diseases in Singapore increased from 6,238 in 2021 to 6,884 in 2022. Therefore, the increasing prevalence of cardiovascular diseases is expected to propel the growth of the vascular closure devices market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13201&type=smp

The vascular closure devices market covered in this report is segmented –

1) By Type: Passive Approximators, Active Approximators, External Hemostatic Devices
2) By Access: Femoral Access, Radial Access
3) By End User: Acute Care Facilities, Hospitals, Clinics, Other End Users

Major companies operating in the vascular closure devices market are developing innovative products, such as the AZUR Vascular Plug, to increase profitability in the market. The AZUR Vascular Plug is a medical device that closes or blocks a blood vessel and is made of a self-expanding nitinol wire mesh. For instance, in July 2021, Terumo Medical Corporation, a Japan-based manufacturer of medical devices, launched the AZUR Vascular Plug for peripheral vascular embolization. It is a specially created plug that may occlude arteries up to 8 mm in diameter and is suggested to slow down or stop blood flow in arteries of the peripheral vasculature. It is compatible with a microcatheter. The AZURTM Vascular Plug has a short deployment length for improved precision and is available in sizes to treat vascular architecture ranging from 2.5mm to 8mm. It has an inner composite membrane of polytetrafluoroethylene (ePTFE) and polyethylene terephthalate (PET) that facilitates mechanical occlusion.

The vascular closure devices market report table of contents includes:

1. Executive Summary
2. Vascular Closure Devices Market Characteristics
3. Vascular Closure Devices Market Trends And Strategies
4. Vascular Closure Devices Market – Macro Economic Scenario
5. Global Vascular Closure Devices Market Size and Growth

.

.

.

32. Global Vascular Closure Devices Market Competitive Benchmarking
33. Global Vascular Closure Devices Market Competitive Dashboard
34. Key Mergers And Acquisitions In Vascular Closure Devices Market
35. Vascular Closure Devices Market Future Outlook and Potential Analysis
36. Appendix

 

Top Major Players :

• Cardinal Health Inc.
• Abbott Laboratories
• Medtronic PLC
• Koninklijke Philips NV
• Boston Scientific Corporation

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model